Glaucoma screening algorithm study for African patients
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a new algorithm to help screen for glaucoma in people of African descent. It aims to improve early detection and diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- Be willing to sign a consent form for the screening process.
- Attend the eye unit at the study hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
This trial uses an artificial intelligence (AI) program to screen for glaucoma in people who have a family history of the disease. It aims to catch glaucoma early, when it can be treated more effectively.
This trial tests whether artificial intelligence can help find glaucoma early in people with diabetes who already get regular eye checks for diabetic eye disease. It may help catch glaucoma sooner without extra tests.
This trial tests an artificial intelligence tool that may help detect glaucoma earlier. It compares AI analysis of eye images between people with glaucoma and healthy volunteers.
This study tests an AI platform that checks for diabetic retinopathy, a common eye problem in people with diabetes. It aims to see if the AI can spot signs of damage early, so you can get treatment sooner.
This trial tests a new AI-powered, do-it-yourself screening system for diabetic retinopathy. It may help find early signs of eye disease in people who haven't had an eye exam in the past year.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.